These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 23799939)
1. A genetic variant of the atrial natriuretic peptide gene is associated with left ventricular hypertrophy in a non-diabetic population--the Malmö preventive project study. Jujić A; Leosdottir M; Östling G; Gudmundsson P; Nilsson PM; Melander O; Magnusson M BMC Med Genet; 2013 Jun; 14():64. PubMed ID: 23799939 [TBL] [Abstract][Full Text] [Related]
2. A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community. Cannone V; Boerrigter G; Cataliotti A; Costello-Boerrigter LC; Olson TM; McKie PM; Heublein DM; Lahr BD; Bailey KR; Averna M; Redfield MM; Rodeheffer RJ; Burnett JC J Am Coll Cardiol; 2011 Aug; 58(6):629-36. PubMed ID: 21798427 [TBL] [Abstract][Full Text] [Related]
3. Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure. Newton-Cheh C; Larson MG; Vasan RS; Levy D; Bloch KD; Surti A; Guiducci C; Kathiresan S; Benjamin EJ; Struck J; Morgenthaler NG; Bergmann A; Blankenberg S; Kee F; Nilsson P; Yin X; Peltonen L; Vartiainen E; Salomaa V; Hirschhorn JN; Melander O; Wang TJ Nat Genet; 2009 Mar; 41(3):348-53. PubMed ID: 19219041 [TBL] [Abstract][Full Text] [Related]
4. Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. Rubattu S; Bigatti G; Evangelista A; Lanzani C; Stanzione R; Zagato L; Manunta P; Marchitti S; Venturelli V; Bianchi G; Volpe M; Stella P J Am Coll Cardiol; 2006 Aug; 48(3):499-505. PubMed ID: 16875975 [TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic peptide and type 2 diabetes development--biomarker and genotype association study. Jujić A; Nilsson PM; Engström G; Hedblad B; Melander O; Magnusson M PLoS One; 2014; 9(2):e89201. PubMed ID: 24586593 [TBL] [Abstract][Full Text] [Related]
6. Atrial natriuretic peptide gene promoter polymorphism is associated with left ventricular hypertrophy in hypertension. Xue H; Wang S; Wang H; Sun K; Song X; Zhang W; Fu C; Han Y; Hui R Clin Sci (Lond); 2008 Jan; 114(2):131-7. PubMed ID: 17672826 [TBL] [Abstract][Full Text] [Related]
7. The atrial natriuretic peptide genetic variant rs5068 is associated with a favorable cardiometabolic phenotype in a Mediterranean population. Cannone V; Cefalu' AB; Noto D; Scott CG; Bailey KR; Cavera G; Pagano M; Sapienza M; Averna MR; Burnett JC Diabetes Care; 2013 Sep; 36(9):2850-6. PubMed ID: 23637347 [TBL] [Abstract][Full Text] [Related]
8. A favorable cardiometabolic profile is associated with the G allele of the genetic variant rs5068 in African Americans: The Multi-Ethnic Study of Atherosclerosis (MESA). Cannone V; Scott CG; Decker PA; Larson NB; Palmas W; Taylor KD; Wang TJ; Gupta DK; Bielinski SJ; Burnett JC PLoS One; 2017; 12(12):e0189858. PubMed ID: 29253899 [TBL] [Abstract][Full Text] [Related]
9. Sex-based differences in metabolic protection by the ANP genetic variant rs5068 in the general population. Ichiki T; Cannone V; Scott CG; Iyer SR; Sangaralingham SJ; Bailey KR; Goetze JP; Tsuji Y; Rodeheffer RJ; Burnett JC Am J Physiol Heart Circ Physiol; 2023 Sep; 325(3):H545-H552. PubMed ID: 37417873 [TBL] [Abstract][Full Text] [Related]
10. Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension. Iaccarino G; Izzo R; Trimarco V; Cipolletta E; Lanni F; Sorriento D; Iovino GL; Rozza F; De Luca N; Priante O; Di Renzo G; Trimarco B Clin Pharmacol Ther; 2006 Dec; 80(6):633-45. PubMed ID: 17178264 [TBL] [Abstract][Full Text] [Related]
11. Cosegregation analysis of natriuretic peptide genes and blood pressure in the spontaneously hypertensive rat. Ye P; West MJ Clin Exp Pharmacol Physiol; 2003 Dec; 30(12):930-6. PubMed ID: 14678232 [TBL] [Abstract][Full Text] [Related]
12. Association of genetic variation in the natriuretic peptide system with cardiovascular outcomes. Ellis KL; Newton-Cheh C; Wang TJ; Frampton CM; Doughty RN; Whalley GA; Ellis CJ; Skelton L; Davis N; Yandle TG; Troughton RW; Richards AM; Cameron VA J Mol Cell Cardiol; 2011 Apr; 50(4):695-701. PubMed ID: 21276798 [TBL] [Abstract][Full Text] [Related]
13. The deletion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension. Pontremoli R; Sofia A; Tirotta A; Ravera M; Nicolella C; Viazzi F; Bezante GP; Borgia L; Bobola N; Ravazzolo R; Sacchi G; Deferrari G J Am Soc Nephrol; 1996 Dec; 7(12):2550-8. PubMed ID: 8989733 [TBL] [Abstract][Full Text] [Related]
14. Corin I555(P568) allele is associated with enhanced cardiac hypertrophic response to increased systemic afterload. Rame JE; Drazner MH; Post W; Peshock R; Lima J; Cooper RS; Dries DL Hypertension; 2007 Apr; 49(4):857-64. PubMed ID: 17296875 [TBL] [Abstract][Full Text] [Related]
15. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Nishikimi T; Yoshihara F; Morimoto A; Ishikawa K; Ishimitsu T; Saito Y; Kangawa K; Matsuo H; Omae T; Matsuoka H Hypertension; 1996 Jul; 28(1):22-30. PubMed ID: 8675258 [TBL] [Abstract][Full Text] [Related]
16. Genetic Variation in Kruppel like Factor 15 Is Associated with Left Ventricular Hypertrophy in Patients with Type 2 Diabetes: Discovery and Replication Cohorts. Patel SK; Wai B; Lang CC; Levin D; Palmer CNA; Parry HM; Velkoska E; Harrap SB; Srivastava PM; Burrell LM EBioMedicine; 2017 Apr; 18():171-178. PubMed ID: 28400202 [TBL] [Abstract][Full Text] [Related]
17. Functional alterations of the Nppa promoter are linked to cardiac ventricular hypertrophy in WKY/WKHA rat crosses. Deschepper CF; Masciotra S; Zahabi A; Boutin-Ganache I; Picard S; Reudelhuber TL Circ Res; 2001 Feb; 88(2):223-8. PubMed ID: 11157676 [TBL] [Abstract][Full Text] [Related]
18. Association of the Ghrelin receptor gene region with left ventricular hypertrophy in the general population: results of the MONICA/KORA Augsburg Echocardiographic Substudy. Baessler A; Kwitek AE; Fischer M; Koehler M; Reinhard W; Erdmann J; Riegger G; Doering A; Schunkert H; Hengstenberg C Hypertension; 2006 May; 47(5):920-7. PubMed ID: 16567594 [TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic peptide is negatively regulated by microRNA-425. Arora P; Wu C; Khan AM; Bloch DB; Davis-Dusenbery BN; Ghorbani A; Spagnolli E; Martinez A; Ryan A; Tainsh LT; Kim S; Rong J; Huan T; Freedman JE; Levy D; Miller KK; Hata A; Del Monte F; Vandenwijngaert S; Swinnen M; Janssens S; Holmes TM; Buys ES; Bloch KD; Newton-Cheh C; Wang TJ J Clin Invest; 2013 Aug; 123(8):3378-82. PubMed ID: 23867623 [TBL] [Abstract][Full Text] [Related]
20. Detection of left ventricular hypertrophy in rats administered a peroxisome proliferator-activated receptor alpha/gamma dual agonist using natriuretic peptides and imaging. Engle SK; Solter PF; Credille KM; Bull CM; Adams S; Berna MJ; Schultze AE; Rothstein EC; Cockman MD; Pritt ML; Liu H; Lu Y; Chiang AY; Watson DE Toxicol Sci; 2010 Apr; 114(2):183-92. PubMed ID: 20044590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]